ID
45182
Beschrijving
Principal Investigator: Mark Purdue, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA MeSH: Carcinoma, Renal Cell,Kidney Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000351 The National Cancer Institute (NCI) genome-wide association study (GWAS) of renal cell carcinoma (RCC) was conducted to investigate common genetic variants associated with RCC risk. The GWAS includes 1,453 RCC cases and 3,531 controls of European background from 4 studies (3 cohort, 1 case-control), scanned using the Illumina InfiniumHumanHap 550, 610 and 660W chips. This project was supported by the Intramural Research Program of the National Institutes of Health and NCI. Data from this GWAS were pooled with those from another GWAS of RCC (2,639 cases and 5,392 controls) conducted in Europe by the International Agency for Research on Cancer and the Centre National de Gènotypage. Findings from this collaboration are described in an upcoming report (Purdue et al. Nature Genetics 2011;43(1):60-65; PMID: 21131975). Only data from the NCI scan are included in this dbGaP submission.
Link
Trefwoorden
Versies (2)
- 20-08-22 20-08-22 - Simon Heim
- 12-10-22 12-10-22 - Adrian Schulz
Houder van rechten
Mark Purdue, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA
Geüploaded op
12 oktober 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000351 NCI Genome-Wide Association Study of Renal Cell Carcinoma
Subject ID, study design [cohort study or case-control study], affection status, and gender of participants with or without renal cell carcinoma.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with or without renal cell carcinoma.
- Sample ID and subject ID of participants with or without renal cell carcinoma.
- Subject ID, study design [cohort study or case-control study], affection status, and gender of participants with or without renal cell carcinoma.
Similar models
Subject ID, study design [cohort study or case-control study], affection status, and gender of participants with or without renal cell carcinoma.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with or without renal cell carcinoma.
- Sample ID and subject ID of participants with or without renal cell carcinoma.
- Subject ID, study design [cohort study or case-control study], affection status, and gender of participants with or without renal cell carcinoma.
C2348585 (UMLS CUI [1,2])
C0007328 (UMLS CUI [1,2])